Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.003 |